Torlakovic et al. compared the anti-cyclin D1 antibodies, including monoclonal SP4, P2D11F11, and DCS-6 as well as polyclonal CP236 and 06-137, in malignant lymphomas [44]. Here, CCND1 is linked to lymphoma.